Specialty Pharma ApS

CVR number: 38476599
Parcelvej 11, 2840 Holte
uhs@specialtypharma.dk
tel: 21127210
www.specialtypharma.dk

Income statement (kDKK)

20192020202120222023
Fiscal period length1212121212
Net sales
Gross profit819.27943.77639.301 023.44292.69
Employee benefit expenses- 833.55- 983.19- 704.77- 963.49- 183.75
EBIT-14.28-39.42-65.4759.94108.94
Other financial expenses-0.03-0.50-1.70
Pre-tax profit-14.28-39.45-65.9758.24108.94
Income taxes21.74-17.12-28.25
Net earnings-14.28-39.45-44.2341.1380.69

Assets (kDKK)

20192020202120222023
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables81.1673.5218.82128.25
Current deferred tax assets21.742.62
Short term receivables total81.1673.5221.7421.44128.25
Other current investments18.00
Cash and bank deposits44.53105.94101.8594.3434.07
Cash and cash equivalents44.53105.94101.8594.3452.07
Balance sheet total (assets)125.69179.46123.59115.78180.33

Equity and liabilities (kDKK)

20192020202120222023
Share capital50.0050.0050.0050.0050.00
Retained earnings20.666.37-33.08-77.31-36.18
Profit of the financial year-14.28-39.45-44.2341.1380.69
Shareholders equity total56.3716.92-27.3113.8294.51
Non-current liabilities total
Short-term deferred tax liabilities25.63
Other non-interest bearing current liabilities69.32162.54150.90101.9660.19
Current liabilities total69.32162.54150.90101.9685.82
Balance sheet total (liabilities)125.69179.46123.59115.78180.33
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.